source
- GSK receives accelerated FDA approval for oral lung cancer drug neladalkibGSK announced that the U.S. Food and Drug Administration granted accelerated approval to its oral lung cancer therapy neladalkib. The approval comes as part of the company's $10.6 billion acquisit…
- React Health issues voluntary recall of Luna G3 BPAP devices over data handling errorReact Health (operating as 3B Medical) announced a voluntary correction of certain Luna G3 BPAP System units (model LG3800-30VT) because a data handling issue can produce incorrect therapy pressure…